BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17330370)

  • 1. Pseudomonas aeruginosa bacteremia at a tertiary care center: a cohort study.
    Sfeir PF; Choucair JE; Berbari EF
    J Med Liban; 2006; 54(4):191-5. PubMed ID: 17330370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudomonas aeruginosa bacteremia in patients with HIV infection: clinicoepidemiologic study of 17 episodes].
    Salavert Lletí S; Navarro Ibáñez V; Roig Rico P; Bretón Martínez JR; Ponz Díez F; López Aldeguer J; Gobernado Serrano M
    Rev Clin Esp; 1996 Oct; 196(10):684-91. PubMed ID: 9005471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
    Schechner V; Nobre V; Kaye KS; Leshno M; Giladi M; Rohner P; Harbarth S; Anderson DJ; Karchmer AW; Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2009 Mar; 48(5):580-6. PubMed ID: 19191643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
    Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.
    Schechner V; Gottesman T; Schwartz O; Korem M; Maor Y; Rahav G; Karplus R; Lazarovitch T; Braun E; Finkelstein R; Lachish T; Wiener-Well Y; Alon D; Chowers M; Bardenstein R; Zimhony O; Paz A; Potasman I; Giladi M; Schwaber MJ; Klarfeld-Lidji S; Hochman M; Marchaim D; Carmeli Y
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):38-45. PubMed ID: 21763093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
    Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia.
    Scheetz MH; Bolon MK; Scarsi KK; Fotis MA; Postelnick MJ
    J Infect; 2006 Feb; 52(2):105-10. PubMed ID: 15904961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
    Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteremia caused by Pseudomonas aeruginosa in patients with AIDS].
    Bouza Santiago E; Blázquez Garrido R; Rodríguez-Creixems M; Moreno Guillén S; Miralles Martín P; Alonso Fernández R
    Rev Clin Esp; 1996 Oct; 196(10):698-702. PubMed ID: 9005473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
    Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
    Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.
    Morata L; Cobos-Trigueros N; Martínez JA; Soriano A; Almela M; Marco F; Sterzik H; Núñez R; Hernández C; Mensa J
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4833-7. PubMed ID: 22751533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiologic agents and risk factors in nosocomial urinary tract infections].
    Akkoyun S; Kuloğlu F; Tokuç B
    Mikrobiyol Bul; 2008 Apr; 42(2):245-54. PubMed ID: 18697422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis.
    Lemaire X; Morena M; Leray-Moragués H; Henriet-Viprey D; Chenine L; Defez-Fougeron C; Canaud B
    Blood Purif; 2009; 28(1):21-8. PubMed ID: 19325236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and prognosis of Pseudomonas aeruginosa bacteremia in a tertiary care center.
    Sifuentes-Osornio J; Gonzalez R; Ponce-de-Leon A; Guerrero ML
    Rev Invest Clin; 1998; 50(5):383-8. PubMed ID: 9949667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.